Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 3 1

Status

Completed 6Recruiting 2Withdrawn 1Unknown 1Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 4NIH 1NETWORK 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gynecologic 6Other neoplasm 3

Conditions

Uterine Cervical Neoplasms 5Uterine Cervical Dysplasia 3Precancerous Conditions 2Papillomavirus Infections 2Atypical Squamous Cells of the Cervix 1

Interventions

Paclitaxel 264Carboplatin 246Cisplatin 153Bevacizumab 104Gemcitabine 78Topotecan 77liposomal doxorubicin 67pembrolizumab 60Docetaxel 56Cyclophosphamide 50Taxes 48Radiotherapy 44olaparib 43Surveys and Questionnaires 43Doxorubicin 43Filgrastim 42Brachytherapy 37Drug Therapy 31niraparib 28Blood Specimen Collection 28Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 26human papillomavirus vaccine, L1 type 16, 18 24Peripheral Blood Stem Cell Transplantation 23atezolizumab 22Oxaliplatin 22Pemetrexed 21Nivolumab 21Hyperthermic Intraperitoneal Chemotherapy 21Etoposide 21Immunoglobulin G 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Completed × Vaginal Smears × Gynecologic × Clear all
NCT03713710 2022-11-16

HPV

University of Alabama at Birmingham

Phase NA Completed
335 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT01550783 2020-07-31

Home-Based or Clinic-Based Human Papillomavirus (HPV) Screening

University of Washington

Phase NA Completed
1,335 enrolled
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections, Atypical Squamous Cells of the Cervix

NCT04072913 2019-08-28

MMP-HPV

University Hospital, Bordeaux

Phase NA Completed
216 enrolled
Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT03713697 2018-10-22

HPV

University of Alabama at Birmingham

Phase NA Completed
484 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT00003384 2015-05-29

Protein Expression as a Potential Diagnostic Biomarker of Cervical Dysplasia and/or Cancer

GOG Foundation

Phase NA Completed
684 enrolled
GynecologicOther neoplasm

Uterine Cervical Dysplasia, Precancerous Conditions

NCT00462813 2013-08-07

Diindolylmethane in Treating Patients With Abnormal Cervical Cells

National Cancer Institute (NCI)

Phase 3 Completed
3,000 enrolled
GynecologicOther neoplasm

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡